Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Royal Mail, Haleon, eEnergy

(Sharecast News) - Analysts at Berenberg lowered their target price on postal service operator Royal Mail from 575.0p to 480.0p on Thursday but reiterated their 'buy' rating on the stock. Berenberg said weaker parcel numbers and poor employee relations had hampered cost reductions for Royal Mail, leading the company to reduce its group underlying earnings outlook for the year by more than 40%.

However, while Berenberg thinks that the risk of industrial action in the next few months will likely remain an overhang in the short-term, in the mid-term, it believes the shares remain "unfairly discounted", given the value of its European business and the improvement in its UK market position over the past few years.

Even before thinking about the potential costs of any strikes, RMG has estimated that tensions with the unions will mean that the UK business foregoes approximately £200.0m in previously expected cost savings over the course of the year, thanks to stalled productivity initiatives. According to Berenberg, when combined with slightly weaker-than-expected parcel volumes, this means the UK business may now barely turn a profit in the 2022-23 trading year - implying a roughly 40% downgrade to group EBIT for the year.

The German bank also highlighted that management had long resisted investor calls to split the UK and international businesses, but said pressures on its domestic operations meant that it was now more open to a split.

"Given the discount on which the shares now trade, this would almost certainly be in the interests of shareholders, in our view, though it may well just be a gambit to put more pressure on the unions - if the UK operation loses the financial backstop of GLS then redundancies may well be a more realistic prospect than pay rises," said the analysts.

"The shares are now trading below the value of the GLS division: On our reduced forecasts, the group now trades on 6.5x CY 2023E EBIT - a circa 30% discount to history. Our base valuation for the GLS division is circa 390.0p, equating to circa 140% of the current value of the group's shares. While we still think a breakup of the group is unlikely, overall we think this should help to act as a valuation backstop for the shares," said Berenberg.

Citi initiated coverage of GlaxoSmithKline's consumer health spinoff Haleon on Thursday with a 'buy' rating and 360.0p price target.

"We see the company as the best vehicle to play the secular attractions of Consumer Health, facilitated by Haleon's scale and its exposure to staples segments where it can more easily outperform," it said.

Citi said its analysis suggested Haleon's 4-6% OSG target was achievable, and while consumer health specifics can sometimes tempt companies into overearning, the group's P&L structure was well invested to support a low double-digit total shareholder return.

"Coupled with a strategic optionality offering a floor to valuation, we believe the stock offers the best of both worlds: consumer health 'defendability' and staples ability to outgrow," said Citi.

Analysts at Canaccord Genuity initiated coverage on energy services provider eEnergy with a 'buy' rating and 15.0p target price on Thursday, valuing the group squarely in the middle of its utility service peers in the UK.

Built up through three key acquisitions over the past two years, Canaccord Genuity said eEnergy had "evolved" its energy efficiency offering with the historic lighting-as-a-service providing the largest element of its energy services offering.

However, Canaccord said the group was now positioned with multi-product offerings, and stated the addition of energy management capabilities offered procurement along with "extensive compliance and consultancy services" focussed on the public sector, charities, and commercial and industrial customers.

"Given current utility market trends, we expect organic growth in excess of 20% per year for the foreseeable future. In addition, it is currently expanding into EV charging and solar panels, provided to customers with third-party financing," said Canaccord.

The Canadian bank noted that eEnergy's focus over the last six months will be on the integration of previous acquisitions to achieve "a strong start to the trading year".

Canaccord also highlighted that as a group, eEnergy remains acquisitive, with expected targeted acquisitions going forward.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Broker tips: Volution, Videndum
(Sharecast News) - Jefferies reiterated its 'buy' rating and 510.0p target price on Volution on Wednesday as it said the company's ability to drive margins higher, through both revenue mix and efficiency, is more than offsetting the challenging market backdrop to deliver ongoing earning upgrades.
Broker tips: Marlowe, Fevertree
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on software and services firm Marlowe from 720.0p to 710.0p on Tuesday but said the group's divestment of certain Governance, Risk and Compliance software and service assets had left it with a "much cleaner and simpler-to-understand equity story".
Broker tips: JD Sports, NatWest
(Sharecast News) - Barclays downgraded JD Sports on Monday to 'equalweight' from 'overweight' and cut its price target for the stock to 140.0p from 165.0p after the retailer announced the acquisition of US rival Hibbett last week for $1.1bn.
Broker tips: NatWest, Pensionbee, Greggs
(Sharecast News) - Shore Capital reiterated its 'buy' rating on bank NatWest after a forecast-beating first quarter but said it sees the least amount of upside potential in the stock compared with the wider banking sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.